Serum levels of brain-derived neurotrophic factor in alcohol-dependent patients receiving high-dose baclofen

Psychiatry Research

Volumn 240, Issue , 2016, Pages 177-180

  Geisel, Olga ^a   Hellweg, Rainer ^a   Müller, Christian A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alcohol dependence brain derived neurotrophic factor baclofen GABA B receptor agonist RCT

Indexed keywords

BACLOFEN; BRAIN DERIVED NEUROTROPHIC FACTOR; PLACEBO; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG DOSE TITRATION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

ADULT; ALCOHOLISM; BACLOFEN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOUBLE-BLIND METHOD; FEMALE; GABA-B RECEPTOR AGONISTS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84963852490     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.04.007     Document Type: Article

References (34)

1. Akaneya Y., Takahashi M., Hatanaka H. Selective acid vulnerability of dopaminergic neurons and its recovery by brain-derived neurotrophic factor. Brain Res. 1995, 704:175-183.
2. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington DC. Fourth ed.
3. Bolanos C.A., Nestler E.J. Neurotrophic mechanisms in drug addiction. Neuromol. Med. 2004, 5:69-83.
4. Bus B.A., Tendolkar I., Franke B., et al. Serum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J. Biol. Psychiatry: Off. J. World Fed. Soc. Biol. Psychiatry 2012, 13:39-47.
5. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 2003, 4:299-309.
6. Costa M.A., Girard M., Dalmay F., Malauzat D. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. Alcohol Clin. Exp. Res. 2011, 35:1966-1973.
7. Faroni A., Calabrese F., Riva M.A., Terenghi G., Magnaghi V. Baclofen modulates the expression and release of neurotrophins in schwann-like adipose stem cells. J. Mol. Neurosci. 2013, 49:233-243.
8. Geisel O., Banas R., Hellweg R., Müller C.A. Altered serum levels of brain-derived neurotrophic factor in patients with pathological gambling. Eur. Addict. Res. 2012, 18:297-301.
9. Geisel O., Banas R., Schneider M., Hellweg R., Müller C.A. Serum levels of brain-derived neurotrophic factor in patients with internet use disorder. Psychiatry Res. 2013, 209:525-528.
10. Ghorbel M.T., Becker K.G., Henley J.M. Profile of changes in gene expression in cultured hippocampal neurones evoked by the GABAB receptor agonist baclofen. Physiol. Genom. 2005, 22:93-98.
11. Heberlein A., Muschler M., Wilhelm J., et al. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:1060-1064.
12. Huang M.C., Chen C.H., Liu H.C., Chen C.C., Ho C.C., Leu S.J. Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal. Alcohol Clin. Exp. Res. 2011, 35:126-131.
13. Huang M.C., Chen C.H., Liu S.C., Ho C.J., Shen W.W., Leu S.J. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol 2008, 43:241-245.
14. Joe K.H., Kim Y.K., Kim T.S., et al. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. Alcohol Clin. Exp. Res. 2007, 31:1833-1838.
15. Koob G.F. Addiction is a reward deficit and stress surfeit disorder. Front. Psychiatry 2013, 4:72.
16. Koob G.F. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Curr. Top. Behav. Neurosci. 2013, 13:3-30.
17. Lee B.C., Choi I.G., Kim Y.K., et al. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol 2009, 43:265-269.
18. Logrip M.L., Janak P.H., Ron D. Escalating ethanol intake is associated with altered corticostriatal BDNF expression. J. Neurochem. 2009, 109:1459-1468.
19. McGough N.N., He D.Y., Logrip M.L., et al. RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J. Neurosci. 2004, 24:10542-10552.
20. Moonat S., Sakharkar A.J., Zhang H., Pandey S.C. The role of amygdaloid brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein and dendritic spines in anxiety and alcoholism. Addict. Biol. 2011, 16:238-250.
21. Müller C.A., Geisel O., Banas R., Heinz A. Current pharmacological treatment approaches for alcohol dependence. Expert Opin. Pharmacother. 2014, 15:471-481.
22. Müller C.A., Geisel O., Pelz P., et al. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial. Eur. Neuropsychopharmacol. 2015, 25:1167-1177.
23. Pastor A., Lloyd-Jones M., Currie J. Reply to Dr Rolland et al. re: "Baclofen for alcohol-dependence: anticraving or partial substitution?. J. Clin. Psychopharmacol. 2013, 33:281-282.
24. Pierce R.C., Bari A.A. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev. Neurosci. 2001, 12:95-110.
25. Polyakova M., Stuke K., Schuemberg K., Mueller K., Schoenknecht P., Schroeter M.L. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. J. Affect. Disord. 2015, 174:432-440.
26. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
27. Rolland B., Bordet R., Deheul S., Cottencin O. Baclofen for alcohol-dependence: anticraving or partial substitution?. J. Clin. Psychopharmacol. 2013, 33:280-281.
28. Russo S.J., Mazei-Robison M.S., Ables J.L., Nestler E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 2009, 56(1):S73-S82.
29. Sartorius A., Hellweg R., Litzke J., et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009, 42:270-276.
30. Tapocik J.D., Barbier E., Flanigan M., et al. microRNA-206 in rat medial prefrontal cortex regulates BDNF expression and alcohol drinking. J. Neurosci. 2014, 34:4581-4588.
31. Varani A.P., Moutinho Machado L., Balerio G.N. Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice. Synapse 2014, 68:508-517.
32. WHO, 1994. Internationale Klassifikation Psychischer Störungen ICD-10 Kapitel V (F) Forschungskriterien. In: Dilling, H., Mombour, W., Schmidt, M.H., Schulte-Warkwort, E., (eds.), Huber, Bern.
33. Xu R., Duan S.R., Zhao J.W., Wang C.Y. Changes in expression of BDNF and its receptors TrkB and p75NTR in the hippocampus of a dog model of chronic alcoholism and abstinence. Braz. J. Med. Biol. Res. 2015, 48:703-710.
34. Ziegenhorn A.A., Schulte-Herbruggen O., Danker-Hopfe H., et al. Serum neurotrophins--a study on the time course and influencing factors in a large old age sample. Neurobiol. Aging 2007, 28:1436-1445.